“Have you been diagnosed with Hepatitis C? Are you a Baby Boomer – born between 1945 – 1965, and uncertain about your diagnosis? Do you write and understand English?”
General News
Overview: CMS has finalized its decision to reimburse for HCV screening in primary care settings, for individuals who are Medicare eligible and either “high risk” or born between 1945-1965. “High risk” is defined as persons with a current or past history of illi...
On October 10, 2014, FDA approved HARVONI a fixed-dose combination tablet of ledipasvir 90 mg, a hepatitis C virus (HCV) NS5A inhibitor, and sofosbuvir 400 mg, an HCV nucleotide analog NS5B polymerase inhibitor. Harvoni is indicated for the treatment of chronic hepatitis C (CHC) ...
The draft clinical criteria for the use of Hep C medication Sofosbuvir (Sovaldi) was presented to the NYS Department Of Health Drug Utilization Review Board (DURB) on Thursday, September 18, 2014.
Governor Andrew M. Cuomo today signed into law a bill that increases access to hepatitis C, or HCV, tests by allowing physicians and nurse practitioners to authorize registered nurses, when appropriate, to administer the test to a patient without the need for a patient-specific o...
A coalition of leading hepatitis C advocacy organizations and medical experts today called on Health and Human Services Secretary Sylvia Mathews Burwell to take leadership in eliminating harmful and discriminatory barriers to hepatitis C treatment access.
RRU Research is seeking participants for a 2 hour focus group .
Presidential Proclamation | World Hepatitis Day 2014 See original post here. – – – – – – – BY THE PRESIDENT OF THE UNITED STATES OF AMERICA A PROCLAMATION Around the world, one in twelve people are living with viral hepatitis. In the Unit...
The Council of the City of New York Proclamation Whereas: Hepatitis B is a silent epidemic that affects 1.2 million Americans, most of whom do not know they are infected with the virus. Chronic hepatitis B can damage the liver for up to 20-30 years without symptoms, and can lead ...
State health departments receive less than $1 dollar in federal funding for every person living with viral hepatitis for the Viral Hepatitis Prevention Coordinator (VHPC) program.
